• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在急性呼吸窘迫综合征患者中持续长时间输注苯磺顺阿曲库铵。

Continuously protracted infusion of cisatracurium besilate in patients with ARDS.

作者信息

Yuan Ziming, Pan Lei, Wang Yang, Wang Wei

机构信息

Department of Critical Care Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai, 200233, China.

Department of Respiratory Diseases, Shanghai Public Health Clinical Center, 2901 Caolang Road, Shanghai, 201508, China.

出版信息

Ann Med Surg (Lond). 2022 May 2;77:103718. doi: 10.1016/j.amsu.2022.103718. eCollection 2022 May.

DOI:10.1016/j.amsu.2022.103718
PMID:35638041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9142704/
Abstract

BACKGROUND

Acute respiratory distress syndrome (ARDS) is still associated with significant mortality, especially the elderly and those with comorbidities are at highest risk of death. Neuromuscular blocking agents (NMBAs) are used in a large but highly variable proportion of patients with ARDS.

CASE PRESENTATION

We describe the case of one critically ill patient with serious ARDS, because of virus pneumonia. In spite of the reduced tidal volume to 4-6 mL/kg of predicted body weight (PBW) and prone position were applied timely, the irresistible progress of disease leaded to an amazing prolonged application of deep sedation and analgesia, as well as NMBA, for the purpose of lung-protective mechanical ventilation.

RESULT

The clinical and biochemical parameters guided us toward the recognition that cisatracurium, bolus of 0.1 mg/kg followed by a median infusion rate of 1.91 (1.43-9.52) μg/kg.min, combined with continuous infusion of midazolam 3.43 (2.06-6.17) mg/kg.d and remifentanil 3.79 (3.43-8.57) μg/kg.h is efficacious and suitable for continuous muscle paralysis.

CONCLUSION

The intensive care unit (ICU)-acquired weakness (ICU-AW) was inevitable. Besides, an increased demand on drug concentration with the extension of medication time was observed as well.

摘要

背景

急性呼吸窘迫综合征(ARDS)的死亡率仍然很高,尤其是老年人和患有合并症的患者死亡风险最高。神经肌肉阻滞剂(NMBAs)在很大比例但差异很大的ARDS患者中使用。

病例介绍

我们描述了一例因病毒性肺炎导致严重ARDS的重症患者。尽管潮气量降至预测体重(PBW)的4-6 mL/kg并及时采用俯卧位,但疾病的不可阻挡进展导致为了肺保护性机械通气而令人惊讶地长时间应用深度镇静、镇痛以及NMBA。

结果

临床和生化参数引导我们认识到,顺式阿曲库铵,静脉推注0.1 mg/kg,随后中位输注速率为1.91(1.43-9.52)μg/kg·min,联合持续输注咪达唑仑3.43(2.06-6.17)mg/kg·d和瑞芬太尼3.79(3.43-8.57)μg/kg·h,对于持续肌肉麻痹是有效且合适的。

结论

重症监护病房(ICU)获得性肌无力(ICU-AW)是不可避免的。此外,还观察到随着用药时间延长对药物浓度的需求增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fc/9142704/f4a543da23fb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fc/9142704/d1c5a42cc820/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fc/9142704/6727374b9d10/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fc/9142704/dcfbf792050d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fc/9142704/f4a543da23fb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fc/9142704/d1c5a42cc820/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fc/9142704/6727374b9d10/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fc/9142704/dcfbf792050d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fc/9142704/f4a543da23fb/gr4.jpg

相似文献

1
Continuously protracted infusion of cisatracurium besilate in patients with ARDS.在急性呼吸窘迫综合征患者中持续长时间输注苯磺顺阿曲库铵。
Ann Med Surg (Lond). 2022 May 2;77:103718. doi: 10.1016/j.amsu.2022.103718. eCollection 2022 May.
2
Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.重症监护医学中的最佳证据:神经肌肉阻滞剂在早期严重急性呼吸窘迫综合征中的作用。
Can J Anaesth. 2012 Jan;59(1):105-8. doi: 10.1007/s12630-011-9615-2. Epub 2011 Nov 1.
3
Sedation and neuromuscular blocking agents in acute respiratory distress syndrome.急性呼吸窘迫综合征中的镇静和神经肌肉阻滞剂
Ann Transl Med. 2017 Jul;5(14):291. doi: 10.21037/atm.2017.07.19.
4
Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials.急性呼吸窘迫综合征中神经肌肉阻滞剂的应用:随机试验的最新系统评价与荟萃分析
Intensive Care Med Exp. 2020 Oct 23;8(1):61. doi: 10.1186/s40635-020-00348-6.
5
The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.神经肌肉阻滞剂在急性呼吸窘迫综合征中的应用效果:一项随机对照试验的系统评价和荟萃分析。
Minerva Anestesiol. 2021 Mar;87(3):341-350. doi: 10.23736/S0375-9393.20.14783-7. Epub 2020 Dec 10.
6
To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.是否阻断:急性呼吸窘迫综合征中神经肌肉阻滞的新进展。
Ann Pharmacother. 2020 Sep;54(9):899-906. doi: 10.1177/1060028020910132. Epub 2020 Feb 28.
7
Association between tidal volume size, duration of ventilation, and sedation needs in patients without acute respiratory distress syndrome: an individual patient data meta-analysis.无急性呼吸窘迫综合征患者的潮气量大小、通气时间与镇静需求之间的关系:一项个体患者数据荟萃分析。
Intensive Care Med. 2014 Jul;40(7):950-7. doi: 10.1007/s00134-014-3318-4. Epub 2014 May 9.
8
Prolonged weakness after cisatracurium infusion: a case report.顺式阿曲库铵输注后出现的持续性肌无力:一例报告。
Crit Care Med. 1998 Jul;26(7):1290-2. doi: 10.1097/00003246-199807000-00038.
9
Neuromuscular blockers in early acute respiratory distress syndrome.早期急性呼吸窘迫综合征中的神经肌肉阻滞剂。
N Engl J Med. 2010 Sep 16;363(12):1107-16. doi: 10.1056/NEJMoa1005372.
10
Application of Neuromuscular Blockers in Patients with ARDS in ICU: A Retrospective Study Based on the MIMIC-III Database.神经肌肉阻滞剂在重症监护病房急性呼吸窘迫综合征患者中的应用:基于MIMIC-III数据库的回顾性研究
J Clin Med. 2023 Feb 27;12(5):1878. doi: 10.3390/jcm12051878.

本文引用的文献

1
Changes in muscle ultrasound for the diagnosis of intensive care unit acquired weakness in critically ill patients.重症患者 ICU 获得性肌无力的肌肉超声变化。
Sci Rep. 2021 Sep 14;11(1):18280. doi: 10.1038/s41598-021-97680-y.
2
Pathophysiology and management of critical illness polyneuropathy and myopathy.危重病性多发性神经病和肌病的病理生理学和治疗。
J Appl Physiol (1985). 2021 May 1;130(5):1479-1489. doi: 10.1152/japplphysiol.00019.2021. Epub 2021 Mar 18.
3
The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines.
SCARE 2020 指南:更新共识手术病例报告(SCARE)指南。
Int J Surg. 2020 Dec;84:226-230. doi: 10.1016/j.ijsu.2020.10.034. Epub 2020 Nov 9.
4
Analgesia and sedation in patients with ARDS.急性呼吸窘迫综合征患者的镇痛与镇静。
Intensive Care Med. 2020 Dec;46(12):2342-2356. doi: 10.1007/s00134-020-06307-9. Epub 2020 Nov 10.
5
COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.COVID-19 感染:病毒巨微血管性凝血障碍和血栓栓塞/预防和治疗管理。
J Cardiovasc Pharmacol Ther. 2021 Jan;26(1):12-24. doi: 10.1177/1074248420958973. Epub 2020 Sep 14.
6
ICU outcomes can be predicted by noninvasive muscle evaluation: a meta-analysis.无创肌肉评估可预测重症监护病房的预后:一项荟萃分析。
Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.02482-2019. Print 2020 Oct.
7
Formal guidelines: management of acute respiratory distress syndrome.正式指南:急性呼吸窘迫综合征的管理
Ann Intensive Care. 2019 Jun 13;9(1):69. doi: 10.1186/s13613-019-0540-9.
8
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征的早期神经肌肉阻滞。
N Engl J Med. 2019 May 23;380(21):1997-2008. doi: 10.1056/NEJMoa1901686. Epub 2019 May 19.
9
ESPEN guideline on clinical nutrition in the intensive care unit.ESPEN 重症监护病房临床营养指南。
Clin Nutr. 2019 Feb;38(1):48-79. doi: 10.1016/j.clnu.2018.08.037. Epub 2018 Sep 29.
10
Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment.急性呼吸窘迫综合征:诊断与治疗的进展。
JAMA. 2018 Feb 20;319(7):698-710. doi: 10.1001/jama.2017.21907.